Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interaction between levodopa and methyldopa.

F B Gibberd, E Small

    British Medical Journal
    |April 14, 1973
    PubMed
    Summary
    This summary is machine-generated.

    Combining methyldopa and levodopa can lower blood pressure in Parkinsonism patients. While severe hypotension did not occur, initiating this drug combination in a hospital setting is recommended for safety.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Social Stigma and Vulnerabilities of Women Living with HIV/AIDS in Kyrgyzstan: Service Providers' Perspectives.

    Families in society : the journal of contemporary human services·2025
    Same author

    Spinal cord compression associated with pseudohypoparathyroidism.

    Journal of the Royal Society of Medicine·2010
    Same author

    Biodiversity in urban habitat patches.

    The Science of the total environment·2005
    Same author

    Kinetics of development and characteristics of antibodies induced in cancer patients against yeast expressed rDNA derived granulocyte macrophage colony stimulating factor (GM-CSF).

    Cytokine·2004
    Same author

    Smell testing: an additional tool for identification of adult Refsum's disease.

    Journal of neurology, neurosurgery, and psychiatry·2004
    Same author

    Regulation of cardiac growth and development by SRF and its cofactors.

    Cold Spring Harbor symposia on quantitative biology·2003
    Same journal

    Muscular pain during therapy with carbenoxolone (Biogastrone).

    British medical journal·2016
    Same journal

    ACUTE INTESTINAL OBSTRUCTION DUE TO INTRA-ABDOMINAL CAUSES.

    British medical journal·2014
    Same journal

    A CASE OF HAEMATIDROSIS.

    British medical journal·2014
    Same journal

    Incidence of ulcer in haematemesis.

    British medical journal·2011
    Same journal

    Pituitary hypothyroidism with impaired renal function.

    British medical journal·2011
    Same journal

    The fenestration operation for otosclerosis.

    British medical journal·2011
    See all related articles

    Area of Science:

    • Pharmacology
    • Neurology
    • Cardiovascular Medicine

    Background:

    • Parkinsonism management often involves levodopa.
    • Hypertension is a common comorbidity in patients with Parkinsonism.
    • Methyldopa is an antihypertensive medication.

    Purpose of the Study:

    • To investigate the interaction between methyldopa and levodopa.
    • To assess the combined hypotensive effect of these drugs.
    • To evaluate the safety of co-administering methyldopa and levodopa.

    Main Methods:

    • Study involved 18 patients diagnosed with Parkinsonism.
    • Assessed the blood pressure response to individual and combined administration of methyldopa and levodopa.
    • Monitored for adverse hypotensive effects.

    Related Experiment Videos

    Main Results:

    • The combination of methyldopa and levodopa induced a significant fall in blood pressure.
    • This effect was observed even with doses that had minimal or no effect individually.
    • No instances of severe hypotension were reported in the study participants.

    Conclusions:

    • Methyldopa can be safely administered to hypertensive patients receiving levodopa.
    • The combined use of methyldopa and levodopa necessitates careful initiation and monitoring.
    • Hospitalization is advised for initiating this combined drug regimen due to potential hypotensive effects.